Nucleus is considering the possibility of making a public offer to acquire 23andMe, contingent on financing, as well as initiating and executing a successful negotiation.
Share this post
Nucleus Genomics explores the possibility of…
Share this post
Nucleus is considering the possibility of making a public offer to acquire 23andMe, contingent on financing, as well as initiating and executing a successful negotiation.